Subjective Tinnitus
16
0
1
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.3%
1 terminated out of 16 trials
92.9%
+6.4% vs benchmark
31%
5 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (16)
Efficacy and Safety of the Soricle for Subjective Tinnitus Relief
tVNS and Myofascial Release in Tinnitus
A Multicenter Study of Noninvasive Neuromodulation Treatment for Subjective Tinnitus
Effects of Music Combined With CBT on Chronic Subjective Tinnitus
The Effects of Weight Loss on Tinnitus Symptoms
OTO-313 in Subjects With Unilateral Subjective Tinnitus
Neck Kinesiotherapy and Massage in Tinnitus Treatment
Neurofeedback for Tinnitus - Does Frequency Specificity Matter?
Tinnitus Retraining Therapy Trial
Collaborative Tinnitus Research at Washington University
Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
Evaluation of Low Dose Laser in Treatment of Tinnitus
Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
Effect of Gabapentin on Idiopathic Subjective Tinnitus